Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement

Launched by I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY · Oct 3, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how to improve care for patients with heart problems who are undergoing surgery to replace joints in their legs. Specifically, the study aims to understand how often heart-related issues and blood clots happen after this type of surgery and how different risk factors and prevention strategies can help reduce these complications. By doing this, researchers hope to find better ways to manage blood-thinning medications to keep patients safe.

To participate in this trial, you need to be at least 18 years old and have a history of heart disease, as well as be scheduled for a joint replacement surgery in your lower limbs. Unfortunately, if you are pregnant, have serious mental health issues, or are experiencing severe heart failure or cancer, you won’t be able to join. If eligible, participants can expect to be closely monitored during and after their surgery to gather important information on how to improve care for future patients with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Informed consent
• • Age older than 18 y.o.
• • Cardiovascular disease
• • Indications for planned lower limb joint replacement surgery
• Exclusion Criteria:
• • Pregnancy
• • Psychiatric disorders
• • Decompensated heart failure or acute heart failure
• • Known diagnosis of cancer